Verastem, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Verastem, Inc. (VSTM) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $556.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $556.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $633.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $26.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2026-06-30 | $556.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $633.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $11.00K 10-K · filed 2026-03-04 | |
| 2025-09-30 | $26.00K 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $48.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $75.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $108.00K 10-K · filed 2025-03-20 | |
| 2024-09-30 | $39.00K 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $70.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $108.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $156.00K 10-K · filed 2024-03-14 | |
| 2023-09-30 | $213.00K 10-Q · filed 2023-11-08 | |
| 2023-03-31 | $275.00K 10-Q · filed 2023-08-08 | $346.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $423.00K 10-K · filed 2023-03-14 | |
| 2022-09-30 | $506.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $597.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $694.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $795.00K 10-K · filed 2022-03-28 | |
| 2021-09-30 | $902.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.01M 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $1.13M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $1.26M 10-K · filed 2021-03-18 | |
| 2020-09-30 | $1.38M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.52M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.65M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.79M 10-K · filed 2020-03-11 | |
| 2019-09-30 | $1.89M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $2.03M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $2.17M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |